AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

06 Nov 2024 17:04:07 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

12 Sep 2024 15:05:27 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

09 Sep 2024 15:05:31 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

03 Sep 2024 15:05:20 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

02 Jul 2024 15:05:04 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

01 Jul 2024 06:00:21 By Nasdaq GlobeNewswire

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

23 May 2024 07:05:46 By Nasdaq GlobeNewswire

Avid Bioservices to Participate at Upcoming Investor Conferences

07 May 2024 15:05:11 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

24 Apr 2024 16:25:33 By Nasdaq GlobeNewswire

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

20 Mar 2024 06:00:10 By Nasdaq GlobeNewswire

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

06 Mar 2024 22:58:48 By Nasdaq GlobeNewswire

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

06 Mar 2024 15:32:07 By Nasdaq GlobeNewswire

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

06 Mar 2024 15:31:28 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

07 Dec 2023 15:05:38 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

30 Nov 2023 15:05:57 By Nasdaq GlobeNewswire

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

08 Nov 2023 07:05:03 By Nasdaq GlobeNewswire

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

17 Oct 2023 07:05:09 By Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

26 Sep 2023 15:05:51 By Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

07 Sep 2023 15:05:25 By Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023

31 Aug 2023 15:05:10 By Nasdaq GlobeNewswire